Aberdeen Asset Management PLC UK lessened its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL) by 9.9% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,724 shares of the business services provider’s stock after selling 1,615 shares during the period. Aberdeen Asset Management PLC UK’s holdings in Stericycle were worth $1,124,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. AXA raised its position in shares of Stericycle by 1.0% during the 2nd quarter. AXA now owns 10,489 shares of the business services provider’s stock worth $801,000 after acquiring an additional 100 shares in the last quarter. Schroder Investment Management Group acquired a new stake in shares of Stericycle during the 2nd quarter worth about $80,497,000. Mcdonald Capital Investors Inc. CA raised its position in shares of Stericycle by 0.6% during the 2nd quarter. Mcdonald Capital Investors Inc. CA now owns 779,590 shares of the business services provider’s stock worth $59,498,000 after acquiring an additional 4,790 shares in the last quarter. Sterling Investment Advisors Ltd. raised its position in shares of Stericycle by 26.2% during the 2nd quarter. Sterling Investment Advisors Ltd. now owns 17,475 shares of the business services provider’s stock worth $1,334,000 after acquiring an additional 3,625 shares in the last quarter. Finally, Vivaldi Asset Management LLC acquired a new stake in shares of Stericycle during the 2nd quarter worth about $8,464,000. 93.58% of the stock is currently owned by institutional investors and hedge funds.

Stericycle, Inc. (NASDAQ SRCL) opened at 70.02 on Thursday. The firm has a 50 day moving average price of $72.67 and a 200 day moving average price of $78.88. The stock’s market capitalization is $5.98 billion. Stericycle, Inc. has a 52 week low of $68.62 and a 52 week high of $88.00.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.02. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. The firm had revenue of $917.70 million for the quarter, compared to analysts’ expectations of $902.81 million. During the same quarter in the prior year, the firm posted $1.18 earnings per share. Stericycle’s revenue for the quarter was up 2.9% compared to the same quarter last year. Equities research analysts predict that Stericycle, Inc. will post $4.60 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/21/stericycle-inc-srcl-shares-sold-by-aberdeen-asset-management-plc-uk.html.

SRCL has been the topic of several research analyst reports. BMO Capital Markets initiated coverage on Stericycle in a research report on Thursday, June 29th. They set a “market perform” rating and a $81.00 target price on the stock. Zacks Investment Research raised Stericycle from a “hold” rating to a “buy” rating and set a $85.00 price target on the stock in a research report on Wednesday, July 5th. Jefferies Group LLC reaffirmed a “buy” rating and set a $108.00 price target on shares of Stericycle in a research report on Thursday, July 13th. BidaskClub raised Stericycle from a “strong sell” rating to a “sell” rating in a research report on Monday, July 24th. Finally, Barclays PLC reaffirmed an “overweight” rating and set a $100.00 price target on shares of Stericycle in a research report on Wednesday, August 9th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $81.25.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.